Cancers may express checkpoint molecules such as cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) and programmed cell death protein ligand 1 (PD-L1), which negatively regulates the activation of T cells (21, 22). Here, CTLA4 is linked to cancer.